info@RegenProtocols.com
561-325-7000
141 NW 20th St., Suite G1 Boca Raton, FL 33431
A staged adjunct peptide protocol that supports hair regeneration after PRP, exosome, or red-light therapy, with screening, titration, and decision checkpoints.
This protocol framework is intended for licensed healthcare professionals. It assumes appropriate clinical training, sterile technique, and regulatory compliance. It is not intended for patient-directed use.
A staged adjunct peptide protocol that supports post-procedural hair regeneration when used with PRP, exosome therapy, and red-light photobiomodulation. The framework defines screening requirements, stepwise selection logic, dosing and titration parameters, objective response thresholds, safety monitoring (including copper surveillance for GHK-Cu), and clinical decision checkpoints that guide escalation, maintenance, or discontinuation.
| Agent | Route | Dose | Frequency |
|---|---|---|---|
| GHK-Cu, topical (preferred initial) | Topical | 0.5% to 1% pharmaceutical-grade cream, a pea-sized amount per treatment zone | Evening application; massage for 2–3 minutes |
| GHK-Cu, injectable (add if topical is insufficient by Week 6) | Subcutaneous | 0.5–1.0 mg | 3 times weekly (for example, Mon/Wed/Fri) |
Clinical synergy: supports VEGF and TGF-β signaling, potentiates the mitochondrial effects of red light, and reduces inflammation while supporting angiogenesis.
Standard initiation begins with GHK-Cu plus BPC-157 for synergistic repair and regenerative signaling. TB-500 is reserved for poor responders only, based on objective thresholds.
